| Expression pattern: |
UP |
| Associated gene: |
LIN28B, Ago2, extracellular vesicles (EVs) |
| Associated microRNA: |
miR-338-3p |
| Biological function: |
promotes cisplatin (DDP) chemoresistance; promotes colony formation; promotes migration and invasion; inhibits apoptosis; promotes tumor growth in vivo |
| Molecular mechanism: |
ceRNA mechanism: circ-SCMH1 sponges miR-338-3p to regulate LIN28B; transferred via extracellular vesicles from DDP-resistant cells to parental cells |
| Biological pathway or process: |
chemoresistance (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); proliferation (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); RNA Pull-Down; Transfection; MTT; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model; Bioinformatics Analysis; Clinical Sample Validation; Cohort Study |
| Clinical significance: |
circ-SCMH1 expression was associated with TNM grade and lymph node metastasis of OSCC patients |
| Description: |
circ-SCMH1 is upregulated in DDP-resistant OSCC tissues/cells and promotes cisplatin resistance and malignant phenotypes. It acts as a cytoplasmic ceRNA that sponges miR-338-3p to increase LIN28B, and it can be transferred as an extracellular vesicle cargo to elevate circ-SCMH1 in recipient parental cells. |
| Confidence score: |
0.8324 |